News
The sports supplement creatine may not be effective in building muscle, according to a new study from the University of New ...
The Food and Drug Administration (FDA) has granted accelerated approval to Vanrafia ® (atrasentan) to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid ...
A 15-year-old boy went to the emergency department because he had felt terrible since he woke up that morning. His whole body ...
The FDA granted accelerated approval to atrasentan (Vanrafia) for the reduction of proteinuria in adults with primary ...
Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday for Chinook investors
When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a ...
Though creatine can be found in smaller quantities in foods like salmon, chicken, beef and pork, many people take supplements ...
B vitamins and digestive enzymes to address the main side effects of weight loss drugs, including muscle loss. The brand did ...
You might be familiar with creatine as a bulking supplement, given its reputation for boosting muscle mass and strength. But ...
Creatine has long been a staple supplement for athletes seeking to enhance muscle growth and performance, but new research challenges its effectiveness. A study conducted by researchers at the ...
Sorry, gym rats, but all that creatine you've been relying on? It may have been for nothing, according to a new clinical trial — at least at the dose you were ...
Hosted on MSN22d
First Drug Approved for Ultra-Rare Kidney DiseaseIn the pivotal phase III APPEAR-C3G trial underpinning the approval, iptacopan-treated participants had a 35% reduction from baseline in 24-hour urine protein-to-creatinine ratio ... specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results